SUMMIT THERAPEUTICS INC (SMMT)

US86627T1088 - Common Stock

4.25  +0.19 (+4.68%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-1-31)
Revenue
0.00710.00K1.81M860.00K57.09M
Cost Of Goods
N/AN/AN/AN/A20.00K
Gross Profit
N/AN/AN/AN/A42.99M
Operating Expenses
609.65M64.32M88.00M53.19M45.80M
Research and Development
580.39M51.09M84.34M51.97M50.90M
Selling, General, and Administrative Expenses
30.27M26.74M23.61M19.23M16.40M
Operating Income
-609.65M-63.62M-86.19M-52.33M11.29M
Interest Income/Expense
-5.03M-7.00M-2.42M-200.00K-620.00K
Other Income/Expense
-252.00K300.00K0.00480.00K3.70M
Non Recurring Items
0.00-8.47M0.00-860.00K-5.29M
Income Before Taxes
-614.93M-78.78M-88.60M-52.91M9.08M
Income Tax
N/AN/A0.00-210.00K-820.00K
Net Income
-614.93M-78.78M-88.60M-52.70M9.90M
EBITDA
-609.45M-62.36M-84.84M-50.78M13.06M
 
Per Share Data
EPS Diluted Total Ops
-0.99-0.41-0.96-0.760.57
Non GAAP EPS
-0.15N/AN/A-3.39N/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A75.30%
Profit Margin
N/A-11095.77%-4895.03%-6127.91%17.34%
Operating Profit Margin
N/A-8960.56%-4761.88%-6084.88%19.78%

All data in USD

Charts